BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nonalcoholic fatty liver disease
1
Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
8/5/2021 2:37:04 PM | Browse: 23 | Download: 42
2
Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion
7/12/2021 12:42:13 AM | Browse: 45 | Download: 34
3
PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
7/6/2021 2:31:17 AM | Browse: 23 | Download: 51
4
Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea
6/24/2021 7:26:32 AM | Browse: 23 | Download: 56
5
Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
6/18/2021 5:06:16 AM | Browse: 36 | Download: 72
6
Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
4/29/2021 2:12:02 AM | Browse: 46 | Download: 79
7
G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment
2/26/2021 5:58:37 AM | Browse: 76 | Download: 99
8
Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
1/25/2021 6:05:27 AM | Browse: 69 | Download: 148
9
Chinese medicine formulas for nonalcoholic fatty liver disease: Overview of systematic reviews
1/1/2021 12:36:04 PM | Browse: 106 | Download: 189
10
Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases
12/30/2020 1:59:10 PM | Browse: 131 | Download: 187
11
Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales
12/19/2020 11:55:31 AM | Browse: 105 | Download: 169
12
Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver
12/18/2020 5:58:43 AM | Browse: 110 | Download: 220
13
Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis
12/14/2020 8:10:05 AM | Browse: 154 | Download: 251
14
Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis
11/24/2020 12:41:21 PM | Browse: 132 | Download: 232
15
PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
10/24/2020 2:27:20 AM | Browse: 206 | Download: 305
16
Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?
9/21/2020 4:02:08 PM | Browse: 122 | Download: 261
17
Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation
9/9/2020 11:11:52 AM | Browse: 143 | Download: 344
18
Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling
7/23/2020 5:00:01 AM | Browse: 197 | Download: 243
19
Management of nonalcoholic fatty liver disease in the Middle East
7/7/2020 2:50:53 PM | Browse: 272 | Download: 236
20
Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
6/19/2020 9:46:52 AM | Browse: 279 | Download: 377
21
Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
5/21/2020 12:02:13 PM | Browse: 284 | Download: 342
22
Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα
5/14/2020 3:43:04 AM | Browse: 314 | Download: 317
23
MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism
3/14/2020 3:03:29 PM | Browse: 299 | Download: 309
24
Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis
12/31/2019 7:02:25 AM | Browse: 323 | Download: 516
25
LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
12/6/2019 8:06:37 AM | Browse: 328 | Download: 414
26
MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes
11/14/2019 9:43:48 AM | Browse: 457 | Download: 498
27
Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
9/30/2019 2:14:06 AM | Browse: 457 | Download: 518
28
Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways
9/12/2019 8:50:34 AM | Browse: 230 | Download: 445
29
Exhaled breath analysis in hepatology: State-of-the-art and perspectives
8/14/2019 1:31:33 PM | Browse: 305 | Download: 319
30
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 349 | Download: 289
31
Freeze-dried Si-Ni-San powder can ameliorate high-fat-diet-induced non-alcoholic fatty liver disease
6/28/2019 12:22:27 PM | Browse: 481 | Download: 619
32
Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis
4/26/2019 3:40:00 AM | Browse: 454 | Download: 564
33
Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients
4/13/2019 6:00:06 AM | Browse: 449 | Download: 648
34
Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents
3/28/2019 9:14:41 AM | Browse: 460 | Download: 635
35
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 502 | Download: 446
36
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 376 | Download: 321
37
Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model
12/7/2018 3:57:11 AM | Browse: 560 | Download: 560
38
Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
11/27/2018 1:56:41 PM | Browse: 406 | Download: 430
39
Mutual interaction between oxidative stress and endoplasmic reticulum stress in the pathogenesis of diseases specifically focusing on non-alcoholic fatty liver disease
10/17/2018 8:55:58 AM | Browse: 480 | Download: 462
40
PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease
9/26/2018 9:00:43 AM | Browse: 541 | Download: 487
41
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 593 | Download: 468
42
Associations between nonalcoholic fatty liver disease and ischemic stroke
7/27/2018 4:31:20 PM | Browse: 478 | Download: 451
43
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”
7/19/2018 7:04:34 AM | Browse: 482 | Download: 518
44
Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
6/15/2018 9:13:16 AM | Browse: 548 | Download: 586
45
Mediterranean diet and nonalcoholic fatty liver disease
5/18/2018 2:03:19 AM | Browse: 634 | Download: 510
46
Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
5/18/2018 2:03:19 AM | Browse: 587 | Download: 403
47
Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
5/11/2018 10:51:26 AM | Browse: 486 | Download: 367
48
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
4/19/2018 7:56:07 AM | Browse: 596 | Download: 474
49
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
4/11/2018 8:28:49 AM | Browse: 720 | Download: 477
50
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 731 | Download: 620
Write to the Help Desk
© 2004-2021 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345